ThinkGenetic, Inc.

Join us in honoring Rare Disease Day 2024 with an insightful reflection on the challenges and triumphs faced by millions worldwide. In this article, Michael Bray, PhD, MS, CGC, Clinical Genetic Data Specialist at ThinkGenetic, Inc., shares profound insights into the journey of those living with rare diseases and our unwavering commitment to accelerate change. Discover how we're working tirelessly to shorten the diagnostic odyssey.

Elevating Awareness and Empathy: Rare Disease Day 2024 - ThinkGenetic Join us in reflecting on Rare Disease Day 2024 as Michael Bray, PhD, MS, CGC, Clinical Genetic Data Specialist, shares insights into the challenges faced by those with rare diseases and our commitment at ThinkGenetic, Inc. to shorten the diagnostic journey. Explore our collaborative efforts to raise...

Next week is Rare Disease Day. Are you ready?

This official international awareness-raising campaign happens annually on the last day of February. The focus is to increase awareness among the general public and decision-makers about rare diseases and their influence on the lives of families living with these conditions. With over 300 million people globally living with a rare disease let's come together to advocate for equitable access to diagnosis, treatment, care, and social opportunities.

Not sure where to start? Information, resources, and events schedules are available now at https://loom.ly/EYnCzEg. Rare Disease Day MassBio Rare New England ThinkGenetic, Inc.

ThinkGenetic, Inc. leaders, Ruth Jacob O’Keefe and Dawn Laney are thrilled to be part of the in San Diego this week. This symposium is designed to help researchers and clinicians to better manage and understand diagnostic options for patients with lysosomal diseases, identify areas requiring additional basic and clinical research, public policy and regulatory attention, and identify the latest findings in the natural history of lysosomal diseases.

Join us at the Orphan Drugs & Rare Diseases Global Congress November 16-17 in Boston, MA.

ThinkGenetic will be presenting a case study with PTC Therapeutics discussing the potential of AI in genetic risk assessment. Meet our team, including Chief Executive Officer Ruth O'Keefe, and Commerical Partnerships Julie Walters.

The two-day Congress aims to offer insights into how to improve the diagnostic process and access to treatments of Orphan Drugs and Rare Diseases.

Learn more at https://loom.ly/erjblJs